Results 271 to 280 of about 269,451 (388)

Assessment of synovitis with contrast-enhanced MRI using a whole-joint semiquantitative scoring system in people with, or at high risk of, knee osteoarthritis: the MOST study

Annals of the Rheumatic Diseases, 2010
A. Guermazi, F. Roemer, D. Hayashi, M. Crema, J. Niu, Yuqing Zhang, M. Marra, Avinash M Katur, J. Lynch, G. El-Khoury, K. Baker, L. Hughes, M. Nevitt, D. Felson   +13 more
semanticscholar   +1 more source

Machine Learning–Driven Screening of High‐Activity Antitumor Nanozymes Using an Ensemble Enzymatic Oracle System

Cancer Nexus, EarlyView.
ABSTRACT Nanozymes, by mimicking the catalytic sites of natural enzymes, have emerged as effective substitutes for traditional natural enzymes. However, the relationship between the physicochemical properties and activity of nanozymes is complex and nonlinear.
Guanmeng Zhang, Mutian Yang, Jie Zang, Xiaoli Li, Qinqiu Zhong, Yuxiang Hu, Yumeng Xie, Ludan Zhang, Yuping Qian, Jinna Ren, Yang Peng, Haitao Chen, Jiandong Gao, Ji Wu, Yuguang Wang   +14 more
wiley   +1 more source

Musculoskeletal Disorders and Diseases: Biomechanical Modeling in Sport, Health, Rehabilitation and Ergonomics. [PDF]

Bioengineering (Basel)
Gorce P.
europepmc   +1 more source

Development of the plant collection prescription and the obtaining a liquid extract technology on its basis for prevention and treatment of musculoskeletal system diseases

О. П. Хворост, Т. V. Оproshanska, K. S. Skrebtsova, О. S. Shpychak, А. М. Solomennyi, А. А. Давиденко, О. V. Golyuk   +6 more
openalex   +1 more source

Taste Profile and Relative Bioavailability of Tovorafenib Powder for Oral Suspension and Food Effect of the Tovorafenib Tablet in Healthy Participants

Clinical Pharmacology in Drug Development, EarlyView.
Abstract A pediatric‐friendly powder for oral suspension (PfOS) of tovorafenib, a type II RAF inhibitor, was developed for patients with difficulty swallowing tablets. This open‐label, randomized, phase 1 study (QSC205140) evaluated the taste/palatability of PfOS formulations (n = 12), the relative bioavailability of the PfOS versus tablet formulation,
Yang Zhang, Mike Preigh, Jing Wang, Eleni Venetsanakos, Yujin Wang, Elly Barry, Don Corson   +6 more
wiley   +1 more source

Prevalence of carpal tunnel syndrome and its associated factors among patients with musculoskeletal complaints: a single-center experience from Eastern Ethiopia. [PDF]

BMC Musculoskelet Disord
Yesuf T, Borsamo A, Aragie H, Asmare Y.
europepmc   +1 more source

The Pension Costs of Musculoskeletal Diseases. Estimation of the Economic Burden Borne by the Italian Social Security System

, 2014
Simone Russo, Thierry Mariani, Raffaele Migliorini, Andrea Marcellusi, F.S. Mennini   +4 more
openalex   +1 more source

Reliability of a consensus-based ultrasound score for tenosynovitis in rheumatoid arthritis

Annals of the Rheumatic Diseases, 2012
E. Naredo, M. D’Agostino, R. Wakefield, I. Möller, P. Bálint, E. Filippucci, A. Iagnocco, Z. Karim, L. Terslev, D. Bong, J. Garrido, David Martínez-Hernández, G. Bruyn   +12 more
semanticscholar   +1 more source

Repurposing Acebutolol for Osteoporosis Treatment: Insights From Multi‐Omics and Multi‐Modal Data Analysis

Clinical Pharmacology &Therapeutics, EarlyView.
Overview of a multi‐omics based drug repurposing strategy. The systematic drug repurposing strategy included the following steps: (1) osteoporosis driver signaling networks were identified from multi‐omics data; (2) drug functional modules were obtained using a network fusion approach to integrate drug similarity information; (3) all drugs were ranked ...
Dan‐Yang Liu, Hui Shen, Jonathan Greenbaum, Qiao‐Rong Yi, Shuang Liang, Yue Zhang, Jia‐Chen Liu, Chuan Qiu, Lan‐Juan Zhao, Qing Tian, Kuan‐Jui Su, Zhe Luo, Li Wu, Xiang‐He Meng, Hong‐Mei Xiao, Yun Deng, Yang Li, Dragana Lovre, Vivian Fonseca, Fernando L. Sanchez, Li‐Jun Tan, Hong‐Wen Deng   +21 more
wiley   +1 more source

Comparative evaluation of point-of-care blood gas analysis in rabbit disease models. [PDF]

Front Vet Sci
Park SJ, Cho SE, Huy TXN, Kim S, Kim SH, Park B.   +5 more
europepmc   +1 more source